Pilot Study Evaluating the Effects of Estradiol for Hypogonadal Women With Cystic Fibrosis and Osteopenia
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2019
Price : $35 *
At a glance
- Drugs Estradiol acetate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 16 Apr 2019 Status has been changed to withdrawn prior to enrolment.
- 06 Mar 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Feb 2019 to 1 Apr 2019.
- 07 Feb 2019 Status changed from not yet recruiting to recruiting.